Clinical Trial

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

Name: A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors — clinical trial record (NCT05765851)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and efficacy of DS-1103a combination therapy in participants with advanced solid tumors.

Trial Details

NCT Number	NCT05765851
Lead Sponsor	Daiichi Sankyo Collaborators: AstraZeneca
Conditions	Advanced Solid Tumor
Enrollment	108 participants
Start Date	2023-05-30
Primary Completion	2030-05-15 (estimated)
Study Completion	2030-05-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-11